Plasminogen activation at the cell surface

被引:34
作者
Ellis, V [1 ]
机构
[1] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England
来源
CELL SURFACE PROTEASES | 2003年 / 54卷
关键词
D O I
10.1016/S0070-2153(03)54012-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:263 / 312
页数:50
相关论文
共 218 条
[1]   Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles [J].
An, SSA ;
Carreño, C ;
Marti, DN ;
Schaller, J ;
Albericio, F ;
Llinas, M .
PROTEIN SCIENCE, 1998, 7 (09) :1960-1969
[2]   The topology of plasminogen binding and activation on the surface of human breast cancer cells [J].
Andronicos, NM ;
Ranson, M .
BRITISH JOURNAL OF CANCER, 2001, 85 (06) :909-916
[3]   The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin:: Implications for antiangiogenic strategies [J].
Bajou, K ;
Masson, V ;
Gerard, RD ;
Schmitt, PM ;
Albert, V ;
Praus, M ;
Lund, LR ;
Frandsen, TL ;
Brunner, N ;
Dano, K ;
Fusenig, NE ;
Weidle, U ;
Carmeliet, G ;
Loskutoff, D ;
Collen, D ;
Carmeliet, P ;
Foidart, JM ;
Noël, AS .
JOURNAL OF CELL BIOLOGY, 2001, 152 (04) :777-784
[4]   Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization [J].
Bajou, K ;
Noël, A ;
Gerard, RD ;
Masson, V ;
Brunner, N ;
Holst-Hansen, C ;
Skobe, M ;
Fusenig, NE ;
Carmeliet, P ;
Collen, D ;
Foidart, JM .
NATURE MEDICINE, 1998, 4 (08) :923-928
[5]   Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver [J].
Bezerra, JA ;
Bugge, TH ;
Melin-Aldana, H ;
Sabla, G ;
Kombrinck, KW ;
Witte, DP ;
Degen, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15143-15148
[7]   Tissue-type plasminogen activator: variants and crystal/solution structures demarcate structural determinants of function [J].
Bode, W ;
Renatus, M .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1997, 7 (06) :865-872
[8]  
BORK P, 1995, TRENDS BIOCH SCI, V20
[9]   Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator [J].
Bugge, TH ;
Flick, MJ ;
Danton, MJS ;
Daugherty, CC ;
Romer, J ;
Dano, K ;
Carmeliet, P ;
Collen, D ;
Degen, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5899-5904
[10]  
Bugge TH, 1997, BLOOD, V90, P4522